Cargando…

Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia

Detalles Bibliográficos
Autores principales:	Kabra, Namrata S, Patil, Vaibhav S, Dhanuka, Dolly G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837334/ https://www.ncbi.nlm.nih.gov/pubmed/34827049 http://dx.doi.org/10.4103/ijo.IJO_885_21

Ejemplares similares

Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia
por: Ghaffari, Reza, et al.
Publicado: (2021)

Interferon alpha-2b in giant ocular surface squamous neoplasia
por: Hernandez-Bogantes, Erick, et al.
Publicado: (2016)

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
por: Nuruddin, Murtuza, et al.
Publicado: (2022)

Effect of Autologous Serum Eyedrops on Ocular Surface Disease Caused by Preserved Glaucoma Eyedrops
por: So, Ha-Rim, et al.
Publicado: (2020)

Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients
por: Kaliki, Swathi, et al.
Publicado: (2016)

Topical Interferon Alpha-2b for Treatment of Noninvasive Ocular Surface Squamous Neoplasia with 360° Limbal Involvement
por: Zarei-Ghanavati, Siamak, et al.
Publicado: (2014)

Treatment outcome with interferon alpha 2b in ocular surface squamous neoplasia: Recommendation as primary treatment by peripheral ophthalmologists
por: Meel, Rachna, et al.
Publicado: (2021)

Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits
por: Kawaguchi, Ichiro, et al.
Publicado: (2017)

Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment
por: Shen, Jingjing, et al.
Publicado: (2023)

Influence of Pilocarpine Eyedrops on the Ocular Biometric Parameters and Intraocular Lens Power Calculation
por: Gao, Ruxin, et al.
Publicado: (2023)

Microbial Contamination of Glaucoma Eyedrops Used by Patients Compared With Ocular Medications Used in the Hospital
por: Teuchner, Barbara, et al.
Publicado: (2015)

COVID-19 Ocular Prophylaxis: The Potential Role of Ozonated-Oils in Liposome Eyedrop Gel
por: Rizzo, Stanislao, et al.
Publicado: (2021)

Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b
por: Rocha-de-Lossada, Carlos, et al.
Publicado: (2020)

Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration
por: Shields, Carol L, et al.
Publicado: (2021)

Reduction in Ocular Hypotensive Eyedrops by Ab Interno Trabeculotomy Improves Not Only Ocular Surface Condition But Also Quality of Vision
por: Kashiwagi, Kenji, et al.
Publicado: (2018)

Intralesional and topical interferon therapy following incomplete primary excision of ocular surface squamous neoplasia
por: Rishi, Pukhraj, et al.
Publicado: (2016)

Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients
por: Fariselli, Chiara, et al.
Publicado: (2018)

Pathophysiology of ocular surface squamous neoplasia
por: Gichuhi, Stephen, et al.
Publicado: (2014)

Anti-Inflammatory Effects of Rebamipide Eyedrop Administration on Ocular Lesions in a Murine Model of Primary Sjögren's Syndrome
por: Arakaki, Rieko, et al.
Publicado: (2014)

Effect of Pegylated Interferon and Mitomycin C on Ocular Surface Squamous Neoplasia in Xeroderma Pigmentosum: A Case Series
por: Dirar, Qais S., et al.
Publicado: (2020)

Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects
por: Yoo, Hyounggyoon, et al.
Publicado: (2022)

Delineation of LASIK Flaps with Prednisolone Acetate Eyedrops
por: Fahd, Daoud C, et al.
Publicado: (2014)

Hirsutism following the use of bimatoprost eyedrops for glaucoma
por: Kaliaperumal, Subashini, et al.
Publicado: (2014)

Allergic contact dermatitis caused by dorzolamide eyedrops
por: Lee, Seung-Jun, et al.
Publicado: (2015)

Epidemiology of ocular surface squamous neoplasia in Africa
por: Gichuhi, Stephen, et al.
Publicado: (2013)

Update on pharmacotherapy for ocular surface squamous neoplasia
por: Al Bayyat, Ghada, et al.
Publicado: (2019)

The Management of Ocular Surface Squamous Neoplasia (OSSN)
por: Yeoh, Clarice H. Y., et al.
Publicado: (2022)

Management of ocular surface squamous neoplasia extending up to a filtering trabeculectomy bleb
por: Yadav, Sonal P, et al.
Publicado: (2020)

Rapamycin Eyedrops Increased CD4(+)Foxp3(+) Cells and Prevented Goblet Cell Loss in the Aged Ocular Surface
por: Trujillo-Vargas, Claudia M., et al.
Publicado: (2020)

Topical Omega-3 Fatty Acids Eyedrops in the Treatment of Dry Eye and Ocular Surface Disease: A Systematic Review
por: Paik, Benjamin, et al.
Publicado: (2022)

Topical Chemotherapy for Treating Ocular Surface Squamous Neoplasia with a Combination of Interferon α-2b and 5-Fluorouracil
por: Geng, Wen, et al.
Publicado: (2022)

Intraventricular recombinant alpha-interferon in subacute sclerosing panencephalitis
por: Cianchetti, C., et al.
Publicado: (1991)

Immune Reconstitution Disorders: Spotlight on Interferons
por: Mohei, Hesham, et al.
Publicado: (2019)

Contamination of multi dose eyedrops in the intra and perioperative context
por: Daehn, Tristan, et al.
Publicado: (2021)

Is it time for a moratorium on the use of benzalkonium chloride in eyedrops?
por: D'andrea, Luca, et al.
Publicado: (2022)

Anterior Segment Imaging in Ocular Surface Squamous Neoplasia
por: Ong, Sally S., et al.
Publicado: (2016)

Expression of interleukin-6 in ocular surface squamous neoplasia
por: Eghtedari, Masoomeh, et al.
Publicado: (2019)

Comparison of Ocular Pulse Amplitude Lowering Effects of Preservative-Free Tafluprost and Preservative-Free Dorzolamide-Timolol Fixed Combination Eyedrops
por: Seo, Du Ri, et al.
Publicado: (2015)

Comparative assessment of the cytotoxicity of six anti-inflammatory eyedrops in four cultured ocular surface cell lines, as determined by cell viability scores
por: Ayaki, Masahiko, et al.
Publicado: (2012)

A Novel Phenotype of Junctional Epidermolysis Bullosa with Transient Skin Fragility and Predominant Ocular Involvement Responsive to Human Amniotic Membrane Eyedrops
por: Castiglia, Daniele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9laacderjbe447op0v5nl2jbi7